| Typicality: | 0.276 |
| Saliency: | 0.267 |
| for therapeutic agents | 7 | transitive-object |
| for the design of inhibitors | 3 | purpose |
| enzyme → promise → target | 5 |
| enzyme → be → attractive target | 4 |
| enzyme → be → attractive targets | 4 |
| negative | neutral | positive |
| 0.017 | 0.285 | 0.699 |
| Raw frequency | 13 |
| Normalized frequency | 0.267 |
| Modifier score | 0.500 |
| Perplexity | 461.190 |